Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ventana Medical’s HPV Claims Probed By FDA In Vitro Diagnostic Office

This article was originally published in The Gray Sheet

Executive Summary

Ventana Medical contends that its Inform HPV in-situ hybridization (ISH) probes qualify as analyte-specific reagents and do not require premarket notification, despite FDA's assertions to the contrary
Advertisement

Related Content

FDA, Agendia To Determine Scope Of MammaPrint Premarket Regulation
FDA, Agendia To Determine Scope Of MammaPrint Premarket Regulation
Roche Outlines ASR, Microarray Changes Made In Response To FDA Letter
Roche Outlines ASR, Microarray Changes Made In Response To FDA Letter
A Brewing Debate? ASR Reg Eyed As CMS Readies For Genetic Test Rule
IVD Data Integrity Concerns Are Increasingly 510(k)-Related
Correlogic, FDA To Discuss Status Of OvaCheck Ovarian Cancer Test
AmpliChip Microarray Could Take De Novo Premarket Route, FDA Tells Roche
Multiplex Testing: CDRH Guidance Provokes Array Of Industry Comments
Multiplex Testing: CDRH Guidance Provokes Array Of Industry Comments
Advertisement
UsernamePublicRestriction

Register

MT019991

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel